AnalystsInsight

Christopher Snyder (Morgan Stanley): Analyst Track Record and Price‑Target Accuracy

How often Christopher Snyder’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 922 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

#1109 rank (was #992)4.5★ rating (was 4.6★)

Key takeaways

  • Christopher Snyder ranks #929 of 1,000 analysts in Exent’s scoring (4.5★).
  • 67.8% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 65 days; 64.7% of calls were up 12 months later.
  • Most‑covered stocks: RAL, ROK, DOV, JCI.
  • Free on Exent: Christopher Snyder’s full record, with ratings 3 days after publication.

Christopher Snyder’s track record at a glance

Christopher Snyder of Morgan Stanley ranks #929 of the 1,000 analysts Exent scores, with a 4.5★ rating and a focus on industrials. Over a 7‑year lookback, 67.8% of Christopher’s price targets were reached, 15.4 points above the 52.4% average across all analysts.

MetricChristopher SnyderAll analysts
Price‑target hit rate67.8%52.4%
Median days to hit target65 days91 days
Calls up after 12 months64.7%64.0%
Median 12‑month return of calls+12.7%+13.4%
Hit rate, last 2 years71.8%—
Average worst drop after a call−14.6%—
Ratings in the sample922—
Stocks covered48—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetChristopher Snyder
Under 30 days35.5%
30–90 days23.0%
90–180 days20.6%
Over 180 days21.0%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Christopher Snyder covers most

StockRatings in the sample
RAL23
ROK20
DOV19
JCI18
GWW18
AYI18
EMR17
VRT16

In the past year Christopher’s ratings were 35% Buy, 58% Hold and 7% Sell.

Christopher Snyder’s latest ratings

DateStockActionRatingPrice target
Sep 4, 2026VRTRated: BuyBuy$350.00
Sep 3, 2026LIIReiterated: SellSell$375.00
Sep 2, 2026TTReiterated: BuyBuy$565.00
Sep 2, 2026HUBBReiterated: HoldHold$575.00
Sep 2, 2026ROKReiterated: BuyBuy$545.00
Sep 2, 2026JCIReiterated: BuyBuy$180.00
Aug 28, 2026ETNReiterated: BuyBuy$520.00
Aug 28, 2026EMRReiterated: SellSell$135.00
Aug 10, 2026OTISRated: HoldHold$75.00
Aug 10, 2026MIRRated: HoldHold$23.00
Aug 10, 2026GTESRated: HoldHold$30.00
Aug 10, 2026SWKRated: HoldHold$96.00
  • Sep 4, 2026
    Stock
    VRT
    Action
    Rated: Buy
    Rating
    Buy
    Price target
    $350.00
  • Sep 3, 2026
    Stock
    LII
    Action
    Reiterated: Sell
    Rating
    Sell
    Price target
    $375.00
  • Sep 2, 2026
    Stock
    TT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $565.00
  • Sep 2, 2026
    Stock
    HUBB
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $575.00
  • Sep 2, 2026
    Stock
    ROK
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $545.00
  • Sep 2, 2026
    Stock
    JCI
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $180.00
  • Aug 28, 2026
    Stock
    ETN
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $520.00
  • Aug 28, 2026
    Stock
    EMR
    Action
    Reiterated: Sell
    Rating
    Sell
    Price target
    $135.00
  • Aug 10, 2026
    Stock
    OTIS
    Action
    Rated: Hold
    Rating
    Hold
    Price target
    $75.00
  • Aug 10, 2026
    Stock
    MIR
    Action
    Rated: Hold
    Rating
    Hold
    Price target
    $23.00
  • Aug 10, 2026
    Stock
    GTES
    Action
    Rated: Hold
    Rating
    Hold
    Price target
    $30.00
  • Aug 10, 2026
    Stock
    SWK
    Action
    Rated: Hold
    Rating
    Hold
    Price target
    $96.00

Christopher’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Christopher Snyder’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Christopher Snyder ranks #929 of 1,000 with a 4.5★ rating. 67.8% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 64.7% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Christopher Snyder’s success rate is 55.7% by the ranking source and 67.8% by Exent’s price-target hit-rate backtest, with a median of 65 days to reach a target.

Christopher Snyder (Morgan Stanley) covers 48 stocks, mostly in industrials. The most frequently rated are RAL, ROK, DOV, JCI, GWW.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.